Oncoclinicas do Brasil (ONCO3) - Total Liabilities

Latest as of September 2025: R$7.02 Billion BRL ≈ $1.38 Billion USD

Based on the latest financial reports, Oncoclinicas do Brasil (ONCO3) has total liabilities worth R$7.02 Billion BRL (≈ $1.38 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Oncoclinicas do Brasil annual equity growth to track the company's year-over-year net asset growth rate.

Oncoclinicas do Brasil - Total Liabilities Trend (2013–2024)

This chart illustrates how Oncoclinicas do Brasil's total liabilities have evolved over time, based on quarterly financial data. See Oncoclinicas do Brasil (ONCO3) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Oncoclinicas do Brasil Competitors by Total Liabilities

The table below lists competitors of Oncoclinicas do Brasil ranked by their total liabilities.

Company	Country	Total Liabilities
Amulaire Thermal Technology TW:2241	Taiwan	NT$856.52 Million
Abans Holdings Limited NSE:AHL	India	Rs21.76 Billion
Lang Inc TW:6165	Taiwan	NT$1.61 Billion
Vigo System SA WAR:VGO	Poland	zł53.73 Million
Tucows Inc. TO:TC	Canada	CA$908.23 Million
Dongsung Corporation KO:102260	Korea	₩501.16 Billion
Hitejinro Holdings KO:000140	Korea	₩2.77 Trillion
Climb Global Solutions NASDAQ:CLMB	USA	$343.60 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Oncoclinicas do Brasil's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ONCO3 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.12	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.06	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	7.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.85	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oncoclinicas do Brasil's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oncoclinicas do Brasil (2013–2024)

The table below shows the annual total liabilities of Oncoclinicas do Brasil from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	R$7.82 Billion ≈ $1.53 Billion	+20.27%
2023-12-31	R$6.50 Billion ≈ $1.28 Billion	+16.37%
2022-12-31	R$5.59 Billion ≈ $1.10 Billion	+49.90%
2021-12-31	R$3.73 Billion ≈ $731.40 Million	+37.43%
2020-12-31	R$2.71 Billion ≈ $532.20 Million	+86.55%
2019-12-31	R$1.45 Billion ≈ $285.28 Million	+65.56%
2018-12-31	R$878.19 Million ≈ $172.32 Million	+58.52%
2017-12-31	R$553.99 Million ≈ $108.70 Million	+47.92%
2016-12-31	R$374.51 Million ≈ $73.49 Million	+14.68%
2015-12-31	R$326.58 Million ≈ $64.08 Million	-3.43%
2014-12-31	R$338.17 Million ≈ $66.35 Million	+24.20%
2013-12-31	R$272.27 Million ≈ $53.43 Million	--

About Oncoclinicas do Brasil

SA:ONCO3 Brazil Medical Care Facilities

Market Cap

$117.23 Million

R$597.44 Million BRL

Market Cap Rank

#18540 Global

#175 in Brazil

Share Price

R$0.68

Change (1 day)

-12.82%

52-Week Range

R$0.68 - R$5.70

All Time High

R$19.24